International Journal of Medical Science and Pharmaceutical Research

Background: Kaempferol supplementation (KS) has been used in Iranian medicine to treat several conditions, including rheumatic diseases.

Aim: To review the use of KS in rheumatic diseases.

Methods:  PubMed and Scielo databases were searched for articles on KS and rheumatic diseases until September 2024. 

Results: There are 3 articles with 162 patients. Age varied from 52 to 56.31 ± 8.90 years old, and female gender ranged from 32% to 100%. The kaempferol dosage went from 300 mg to 15 g/day. The study follow-up ranged from 4 to 8 weeks. Concerning outcomes, no significant clinical differences were detected comparing kaempferol and control. A reduction in proinflammatory parameters was observed after kaempferol supplementation: a decrease in tumor necrosis factor and matrix metalloproteinase-1 levels and an increase in interleukin-10. 

Conclusion: This review shows that KS does not seem to have a significant clinical impact on OA treatment. One study showed decreased cytokine levels and a reduction in metalloproteinase. Future studies are, however, needed to confirm the present data.

Kaempferol, Elaeagnus angustifolia, rheumatic diseases, osteoarthritis

1. Yuca H, Özbek H, Demirezer LÖ, Kasil HG, Güvenalp Z. trans-Tiliroside: A potent α-glucosidase inhibitor from the leaves of Elaeagnus angustifolia L. Phytochemistry 2021;188:112795.
2. Ahmadiani A, Hosseiny J, Semnanian S, Javan M, Saeedi F, Kamalinejad M, et al. Antinociceptive and anti-inflammatory effects of Elaeagnus angustifolia fruit extract. J Ethnopharmacol 2000;72:287-92.
3. Mirhydar H. Encyclopedia of plants: indications of plants in the prevention and treatment of diseases. Tehran: Islamic Farhang, 1998.
4. Karimifar M, Soltani R, Hajhashemi V, Sarrafchi S. Evaluation of the effect of Elaeagnus angustifolia alone and combined with Boswellia thurifera compared with ibuprofen in patients with knee osteoarthritis: a randomized double-blind controlled clinical trial. Clin Rheumatol 2017;36(8):1849-1853.
5. Panahi Y, Alishiri GH, Bayat N, Hosseini SM, Sahebkar A. Efficacy of Elaeagnus Angustifolia extract in treating knee osteoarthritis: a randomized controlled trial. EXCLI J 2016;15:203-10.
6. Nikniaz Z, Ostadrahimi A, Mahdavi R, Ebrahimi AA, Nikniaz L. Effects of Elaeagnus angustifolia L. supplementation on serum levels of inflammatory cytokines and matrix metalloproteinases in females with knee osteoarthritis. Complement Ther Med 2014;22(5):864-9.
7. Farahbakhsh S, Arbabian S, Emami F, Rastegar Moghadam B, Ghoshooni H, Noroozzadeh A et al. Inhibition of cyclooxygenase type 1 and 2 enzyme by aqueous Elaeagnus angustifolia extract in mice. Basic Clin Neurosci 2011;2(2):31–37.
8. Cansev A, Sahan Y, Celik G, Taskesen S, Ozbey H. Chemical properties and antioxidant capacity of Elaeagnus angustifolia L fruits. Asian J Chem 2011; 23(6):2661–2665.